PDSNGL™-A is a high-purity bioactive obtained from carefully processed Aloe vera leaves. Produced under controlled conditions to preserve biological activity, and It offers consistent composition, and excellent biocompatibility.
It's acts as anti-inflammatory activity, tissue repair stimulant, promoting cell regeneration, angiogenesis, and, making it a powerful ingredient in wound care, and skin rejuvenation.
Cat Number: EG-RM-PDA-1-2ml
|
PRODUCT INFORMATION |
|
I. TECHNICAL SPECIFICATIONS |
|
|
Structural / Composition Data |
|
|
Structure / Formula |
Polydeoxyribonucleotide; linear polymer of 2'-deoxyribonucleotides |
|
Molecular Weight |
~50 - 1,500 kDa (Mixture of fragments) |
|
Appearance |
Liquid |
|
Purity |
≥ 95% |
|
Solubility |
Soluble in aqueous buffers (e.g., saline, sterile water) |
|
Form(s) Available |
Sterile solution |
|
Stability & Shelf Life |
|
|
Storage |
12 months at 2–8 °C, >24 months at –20 °C |
|
Post-Reconstitution |
6-12 months at 2–8 °C |
|
Stability Notes |
Protect from light |
|
Quality & Compliance |
|
|
QC Tests |
Pending validation |
|
Intended Use |
As instructions |
|
Documentation |
Available on request |
|
II. PREPARATION / RECONSTITUTION |
|
|
General Guidance |
Reconstitute with 1.0 mL sterile water to obtain 100 mg/mL. |
|
Recommendations |
Use within 8–12 hours refrigerated. |
|
III. MECHANISM & BIOLOGICAL FUNCTION |
|
|
Mechanism of Action |
Plant-derived nucleotide signaling → cellular repair activation → fibroblast stimulation and tissue regeneration |
|
Biological Claims |
• Plant-based cellular regeneration |
|
IV. APPLICATIONS |
|
|
Intended Uses |
Targeted drug delivery systems |
|
V. PACKAGING & PRESENTATION |
|
||||||
|
Sizes |
1000 PPM / vials |
5000 PPM / vials |
10000 PPM / vials |
|
|
||
Biotechnologically produced DNA from Aloe Vera plant.
Purified deoxyribonucleotide chains (50–2000 base pairs).
High biocompatibility for safe application
Minimal immunogenicity
Stimulates tissue repair and cellular regeneration
Promotes angiogenesis
Creams
Injectables
Hydrogel matrices
PDSNGL™-A a plant-based DNA, offering regenerative and anti-inflammatory benefits similar to traditional PDRN but from a sustainable source.
Topical products (creams, serums, gels): typically 0.5–5% w/w depending on the desired level of activity and product type.
Device-assisted delivery (microneedling, mesotherapy solutions): generally 0.1–1% in sterile saline or hyaluronic acid carriers.
Injectable or implantable medical devices: concentrations should be determined through in-house validation studies and must comply with local regulatory requirements before clinical use.
Unopened, dry form: Store at 2–8 °C in its original, tightly sealed container, protected from light and moisture. Under these conditions the shelf life is typically 24 months from date of manufacture.
Next-Generation Life Science Products for Everyday Health.